Price $83.78 |
Market Cap
4.26B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
70.0
|
P/B
5.42
|
P/S
9.72
|
Dividend %
-
|
|
P/CF
89.3
|
P/FCF
59.8
|
Op. Cash Flow
92.9K
|
FCF
1.3
|
|
Op. Margin
16.50%
|
Net Margin
13.90%
|
ROE
8.10%
|
ROI
7.50%
|
|
ROA
7.40%
|
EPS Growth
-0.50%
|
Current Ratio
11.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| PetIQ Inc (PETQ) | $36.29 | - | - | 1.06B | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $12.55 | - | - | 10.6B | Strong Buy |
| China Pharma Holdings, Inc. (CPHI) | $0.70 | - | - | 19.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $4.27 | - | - | 166.4M | Strong Buy |
| Harrow Health Inc (HROW) | $7.74 | - | - | 159.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
